Chen, X., Qin, X., Bai, W., Ren, J., Yu, Y., Nie, H., . . . Jiang, Q. (2024). Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation. Advanced Pharmaceutical Bulletin, 14(2), 469. https://doi.org/10.34172/apb.2024.036
Chicago Style (17th ed.) CitationChen, Xi, et al. "Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation." Advanced Pharmaceutical Bulletin 14, no. 2 (2024): 469. https://doi.org/10.34172/apb.2024.036.
MLA (9th ed.) CitationChen, Xi, et al. "Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation." Advanced Pharmaceutical Bulletin, vol. 14, no. 2, 2024, p. 469, https://doi.org/10.34172/apb.2024.036.